Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "AREA[SponsorSearch](Corcept Therapeutics)"
Count: 63
Selected: 0
| NCT ID | Title |
|---|
| NCT05772169 | Study to Determine the Prevalence of Hypercortisolism in Patients With Type 2 Diabetes and Treatment With Korlym® (Mifepristone) (CATALYST) | ||
| NCT05712265 | Study to Evaluate the Effects of a Cytochrome P450 2C19 Inhibitor on the Pharmacokinetics of Miricorilant | ||
| NCT05553470 | Study to Evaluate the Effects of Hepatic Impairment on the Pharmacokinetics of Miricorilant | ||
| NCT05407324 | Dazucorilant in Patients With Amyotrophic Lateral Sclerosis | ||
| NCT05347979 | Effect of Relacorilant on the Pharmacokinetics of the Sensitive P-glycoprotein Substrate Dabigatran Etexilate in Healthy Participants | ||
| NCT05320146 | A Sub Study of the Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT05257408 | Relacorilant in Combination With Nab-Paclitaxel in Advanced, Platinum-Resistant, High-Grade Epithelial Ovarian, Primary Peritoneal, or Fallopian-Tube Cancer | ||
| NCT05117489 | A Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Patients With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT05003713 | Single and Multiple Ascending Dose Study of CORT125236 in Healthy Participants | ||
| NCT04994743 | Safety, Tolerability, and Pharmacokinetic Study of CORT113176 in Healthy Participants | ||
| NCT04990310 | Single Dose Absorption, Distribution, Metabolism, and Excretion Study of [14C]-CORT113176 in Healthy Male Participants | ||
| NCT04795479 | T/QT Study to Investigate the Effect of Relacorilant on Cardiac Repolarization in Healthy Volunteers | ||
| NCT04672512 | Single and Multiple Ascending Dose Study of CORT125329 in Healthy Participants | ||
| NCT04672499 | Single and Multiple Dose Study of Miricorilant (CORT118335) Tablet Formulations in Healthy Participants | ||
| NCT04524403 | Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Obese Adult Patients With Schizophrenia While Taking Antipsychotic Medications (GRATITUDE II) | ||
| NCT04373265 | Study of Relacorilant in Combination With Pembrolizumab for Patients With Adrenocortical Carcinoma Which Produces Too Much Stress Hormone (Cortisol) | ||
| NCT04329949 | Study of Relacorilant in Combination With Nab-Paclitaxel in Patients With Metastatic Pancreatic Ductal Adenocarcinoma | ||
| NCT04308590 | Efficacy and Safety of Relacorilant in Patients With Cortisol-Secreting Adrenal Adenomas | ||
| NCT04249323 | Single and Multiple Ascending Dose Study of CORT113176 in Healthy Participants | ||
| NCT03878264 | Absolute Bioavailability and Metabolism Study of CORT118335 in Healthy Male Participants | ||
| NCT03877952 | Mass Balance Recovery and Metabolite Profile of CORT125281 in Healthy Male Participants | ||
| NCT03877562 | The Effect of CORT118335 on Olanzapine-Induced Weight Gain | ||
| NCT03823703 | Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Miricorilant in Participants With Presumed Nonalcoholic Steatohepatitis (NASH) | ||
| NCT03818256 | This Phase 2, Double Blind, Placebo-controlled, Randomized Study is to Assess the Safety and Efficacy of Miricorilant in Obese Adult With Schizophrenia or Bipolar Disorder Treated With Antipsychotic Medications. | ||
| NCT03776812 | Study of Relacorilant in Combination With Nab-Paclitaxel for Patients With Recurrent Platinum-Resistant Ovarian, Fallopian Tube, or Primary Peritoneal Cancer | ||
| NCT03697109 | A Study of the Efficacy and Safety of Relacorilant in Patients With Endogenous Cushing Syndrome | ||
| NCT03604198 | Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome | ||
| NCT03540836 | A Study to Determine the Relative Bioavailability of Two New Relacorilant Capsule Variants | ||
| NCT03512548 | Study in Healthy Subjects to Determine the Effect of an Inhibitor on Exposure to Relacorilant and Its Metabolites | ||
| NCT03508635 | CORT125134 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT03457597 | Study in Healthy Subjects to Determine the Effect of Relacorilant on Exposure to Probe Substrates for Cytochrome P450s | ||
| NCT03442621 | Relacorilant Food Effect Study in Healthy Subjects | ||
| NCT03437941 | Study to Evaluate CORT125281 in Combination With Enzalutamide in Patients With mCRPC | ||
| NCT03379363 | Retrospective Chart Review Study of Pediatric Patients Treated With Korlym for Cushing Syndrome | ||
| NCT03335956 | CORT125281 Single Ascending Dose (SAD) and Multiple Ascending Dose (MAD) | ||
| NCT03315338 | First-in-human Study in Healthy Subjects | ||
| NCT03259542 | Mifepristone Drug-Drug Interaction Study With CYP3A Inhibitor | ||
| NCT03258372 | Crossover Drug-Drug Interaction Study to Determine Effects of Cytochrome P450 3A on Exposure to Mifepristone and Its Metabolites | ||
| NCT03067376 | A Study Designed to See How [14C]-CORT125134 is Taken up, Broken Down and Removed From the Body | ||
| NCT02922257 | Biomarker Expression in Patients With ACTH-Dependent Cushing's Syndrome Before and After Surgery | ||
| NCT02804750 | Study to Evaluate CORT125134 in Participants With Cushing's Syndrome | ||
| NCT02762981 | Study to Evaluate Relacorilant (CORT125134) in Combination With Nab-paclitaxel in Participants With Solid Tumors | ||
| NCT02663609 | Retrospective Chart Review Study of Korlym for the Treatment of ACTH Independent Cushing's Syndrome | ||
| NCT02014337 | Mifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid Tumors | ||
| NCT01925092 | Mifepristone in Children With Refractory Cushing's Disease | ||
| NCT01371565 | Compassionate Use of CORLUX® (Mifepristone) in the Treatment of Signs and Symptoms of Endogenous Cushing's Syndrome | ||
| NCT00936741 | An Extension Study of CORLUX in the Treatment of Endogenous Cushing's Syndrome | ||
| NCT00796783 | A Study to Confirm Recurrent or Persistent Cushing's Syndrome in Patients With Signs or Symptoms of Hypercortisolemia | ||
| NCT00752843 | A Phase I Study to Determine the Effect of Mifepristone on the Pharmacokinetics of Fluvastatin in Healthy Volunteers | ||
| NCT00698022 | A 4-week Study of Mifepristone in the Prevention of Risperidone-induced Weight Gain in Healthy Male Volunteers |
